drugset / Trial / NCT00250991
Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial
Phase 1/2
Completed
94 enrolled
University of Cincinnati
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedDouble-blindTreatment
Summary
The purpose of this study is determine the effects of using of a combination of two drugs--integrilin (eptifibatide) and activase (recombinant tissue plasminogen activator, rt-PA, or recombinant t-PA)--to dissolve blood clots in patients who have a stroke.
Timeline
- Start
- 2003-07
- Primary completion
- —
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | — | — |
| Subject | Eptifibatide | Other / unclassified | — | — |